Skip to main navigation
  • Mission
  • Programs

        • Programs

          Learn more about our breakthrough programs.

        • Our Programs
        • Scientific Publications
  • People

        • About atai Life Sciences

          Learn about our team, culture and careers.

        • Our Team
        • Company Values
        • Careers
  • Impact
  • Investors

        • Investors

        • Overview
        • News, Events & Presentations
        • Stock Info
        • Analyst Coverage
        • Corporate Governance
        • SEC Filings
        • Shareholder Services

Event Details

Atai - News & Events Submenu

  • News Releases
  • Events
  • Presentations

Neuroscience 2023 Conference

November 14, 2023 from 1:00 PM to 5:00 PM EST

Supporting Materials

Novel 5-HT2A receptor agonists exhibit translational antidepressant and psychedelic drug-like profiles in a model of treatment-resistant depression 3.7 MB

Atai - Investor Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
logo

Atai - Footer Top

  • Mission
  • Model
  • Programs

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Headquartered in Berlin, with offices in New York and London, our vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life.

atai Life Sciences N.V.
Wallstraße 16
10179 Berlin, Germany
Statutory Seat Amsterdam

linkedin twitter mail info@atai.life
  • People
  • Careers
  • News & Insights
  • Contact
Privacy & Cookies Policy

Atai - Footer Bottom

  • Impressum
  • Datenschutzerklärung
© 2024 ATAI Life Sciences N.V., All Rights Reserved